Your browser doesn't support javascript.
loading
Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: the United Kingdom Named Patient Programme.
Khan, F; Ottensmeier, C; Popat, S; Dua, D; Dorey, N; Ellis, S; Szabo, M; Upadhyay, S; Califano, R; Chan, S; Lee, L; Ali, C W; Nicolson, M; Bates, A T; Button, M; Chaudhuri, A; Mulvenna, P; Shaw, H M; Danson, S J.
Afiliação
  • Khan F; Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield S10 2SJ, United Kingdom.
  • Ottensmeier C; Southampton NIHR Experimental Cancer Medicine Center and Southampton University Hospitals NHS Foundation, Southampton SO16 6YD, United Kingdom.
  • Popat S; Royal Marsden Hospital, London SW3 6JJ, United Kingdom.
  • Dua D; Guy's and St. Thomas' NHS Foundation Trust, London SE1 9RT, United Kingdom.
  • Dorey N; Royal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, United Kingdom.
  • Ellis S; Royal Bournemouth Hospital, Bournemouth BH7 7DW, United Kingdom.
  • Szabo M; Southampton NIHR Experimental Cancer Medicine Center and Southampton University Hospitals NHS Foundation, Southampton SO16 6YD, United Kingdom.
  • Upadhyay S; Hull and East Yorkshire Hospitals NHS Trust, Hull HU16 5JQ, United Kingdom.
  • Califano R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, United Kingdom.
  • Chan S; Harrogate and District NHS Foundation Trust, Harrogate HG2 7SX, United Kingdom.
  • Lee L; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, United Kingdom.
  • Ali CW; Beatson West of Scotland Cancer Centre, Glasgow G12 0YN, United Kingdom.
  • Nicolson M; Aberdeen Royal Infirmary, Aberdeen AB25 2ZN, United Kingdom.
  • Bates AT; Southampton NIHR Experimental Cancer Medicine Center and Southampton University Hospitals NHS Foundation, Southampton SO16 6YD, United Kingdom.
  • Button M; Velindre Cancer Centre, Cardiff CF14 2TL, United Kingdom.
  • Chaudhuri A; United Lincolnshire Hospitals NHS Trust, Lincoln LN2 5QY, United Kingdom.
  • Mulvenna P; Newcastle upon Tyne NHS Foundation Trust, Newcastle NE7 7DN, United Kingdom.
  • Shaw HM; University College London Hospitals NHS Foundation Trust, London NW1 2PG, United Kingdom.
  • Danson SJ; Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield S10 2SJ, United Kingdom. Electronic address: s.danson@sheffield.ac.uk.
Eur J Cancer ; 50(10): 1717-1721, 2014 Jul.
Article em En | MEDLINE | ID: mdl-24726055
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Receptores ErbB / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Receptores ErbB / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2014 Tipo de documento: Article